143 related articles for article (PubMed ID: 11963730)
1. [Use of heparin in acute myocardial infarction in routine clinical practice in Germany. Results of the MITRA and MIR registries].
Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J;
Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 11963730
[TBL] [Abstract][Full Text] [Related]
2. [Not Available].
Frilling B; Schiele R; Zahn R; Fischer F; Schneider S; Gitt AK; Heer T; Gottwik M; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J
Z Kardiol; 2002 Feb; 91(2):131-8. PubMed ID: 24562756
[TBL] [Abstract][Full Text] [Related]
3. Characterization and clinical course of patients not receiving aspirin for acute myocardial infarction: results from the MITRA and MIR studies.
Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Baumgärtel B; Asbeck F; Senges J; ;
Am Heart J; 2001 Feb; 141(2):200-5. PubMed ID: 11174332
[TBL] [Abstract][Full Text] [Related]
4. Too little aspirin for secondary prevention after acute myocardial infarction in patients at high risk for cardiovascular events: Results from the MITRA study.
Frilling B; Schiele R; Gitt AK; Zahn R; Schneider S; Glunz HG; Gieseler U; Jagodzinski E; Senges J;
Am Heart J; 2004 Aug; 148(2):306-11. PubMed ID: 15309001
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of a novel anticoagulant, vasoflux, and heparin as adjunctive therapy to streptokinase for acute myocardial infarction: results of the VITAL study (Vasoflux International Trial for Acute Myocardial Infarction Lysis).
Peters RJ; Spickler W; Théroux P; White H; Gibson M; Molhoek PG; Anderson HV; Weitz JI; Hirsh J; Weaver WD
Am Heart J; 2001 Aug; 142(2):237-43. PubMed ID: 11479461
[TBL] [Abstract][Full Text] [Related]
6. Clinical benefit of early reperfusion therapy in patients with ST-elevation myocardial infarction usually excluded from randomized clinical trials (results from the Maximal Individual Therapy in Acute Myocardial Infarction Plus [MITRA Plus] registry).
Koeth O; Zahn R; Gitt AK; Bauer T; Juenger C; Senges J; Zeymer U;
Am J Cardiol; 2009 Oct; 104(8):1074-7. PubMed ID: 19801027
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of enoxaparin in unselected patients with ST-segment elevation myocardial infarction.
Zeymer U; Gitt A; Jünger C; Bauer T; Heer T; Koeth O; Wienbergen H; Zahn R; Senges J
Thromb Haemost; 2008 Jan; 99(1):150-4. PubMed ID: 18217147
[TBL] [Abstract][Full Text] [Related]
8. Excess heparin dosing among fibrinolytic-treated patients with ST-segment elevation myocardial infarction.
Wang TY; Chen AY; Alexander KP; Ohman EM; Gibler WB; Peterson ED; Roe MT
Am J Med; 2008 Sep; 121(9):805-10. PubMed ID: 18724971
[TBL] [Abstract][Full Text] [Related]
9. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
[TBL] [Abstract][Full Text] [Related]
10. Small differences in non-fatal in-hospital reinfarctions complicating acute myocardial infarction as observed in current randomised controlled trials will not essentially influence long-term mortality. Results from the Maximal Individual Therapy in Acute Myocardial Infarction (MITRA) Registry.
Zahn R; Schiele R; Schneider S; Dönges K; Senges J
Z Kardiol; 2003 Oct; 92(10):847-51. PubMed ID: 14579049
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
[TBL] [Abstract][Full Text] [Related]
12. Effect of enoxaparin versus unfractionated heparin in diabetic patients with ST-elevation myocardial infarction in the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) trial.
Morrow DA; Antman EM; Murphy SA; Qin J; Ruda M; Guneri S; Jacob AJ; Budaj A; Braunwald E;
Am Heart J; 2007 Dec; 154(6):1078-84, 1084.e1. PubMed ID: 18035078
[TBL] [Abstract][Full Text] [Related]
13. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
[TBL] [Abstract][Full Text] [Related]
14. Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials.
De Luca G; Marino P
Am Heart J; 2007 Dec; 154(6):1085.e1-6. PubMed ID: 18035079
[TBL] [Abstract][Full Text] [Related]
15. [Reduction of in-hospital mortality and improved secondary prevention after acute myocardial infarction. First results from the registry of secondary prevention after acute myocardial infarction (SAMI)].
Tebbe U; Messer C; Stammwitz E; The GS; Dietl J; Bischoff KO; Schulten-Baumer U; Tebbenjohanns J; Gohlke H; Bramlage P;
Dtsch Med Wochenschr; 2007 Jul; 132(30):1559-66. PubMed ID: 17628839
[TBL] [Abstract][Full Text] [Related]
16. The role of fondaparinux as an adjunct to thrombolytic therapy in acute myocardial infarction: a subgroup analysis of the OASIS-6 trial.
Peters RJ; Joyner C; Bassand JP; Afzal R; Chrolavicius S; Mehta SR; Oldgren J; Wallentin L; Budaj A; Fox KA; Yusuf S;
Eur Heart J; 2008 Feb; 29(3):324-31. PubMed ID: 18245119
[TBL] [Abstract][Full Text] [Related]
17. Does comorbidity account for the excess mortality in patients with major bleeding in acute myocardial infarction?
Spencer FA; Moscucci M; Granger CB; Gore JM; Goldberg RJ; Steg PG; Goodman SG; Budaj A; FitzGerald G; Fox KA;
Circulation; 2007 Dec; 116(24):2793-801. PubMed ID: 18025530
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of enoxaparin versus unfractionated heparin in patients with ST-segment elevation myocardial infarction also treated with clopidogrel.
Sabatine MS; Morrow DA; Dalby A; Pfisterer M; Duris T; Lopez-Sendon J; Murphy SA; Gao R; Antman EM; Braunwald E;
J Am Coll Cardiol; 2007 Jun; 49(23):2256-63. PubMed ID: 17560290
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of unfractionated heparin versus enoxaparin in patients who are obese and patients with severe renal impairment: analysis from the ESSENCE and TIMI 11B studies.
Spinler SA; Inverso SM; Cohen M; Goodman SG; Stringer KA; Antman EM;
Am Heart J; 2003 Jul; 146(1):33-41. PubMed ID: 12851605
[TBL] [Abstract][Full Text] [Related]
20. Randomized comparison of enoxaparin with unfractionated heparin following fibrinolytic therapy for acute myocardial infarction.
Baird SH; Menown IB; Mcbride SJ; Trouton TG; Wilson C
Eur Heart J; 2002 Apr; 23(8):627-32. PubMed ID: 11969277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
